You are here
Generic Celexa Receives FDA Approval
FORT LEE, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global generic pharmaceutical company, today announced that Purepac Pharmaceutical Co., a subsidiary of Alpharma, has received approval from the United States Food and Drug Administration ("FDA") for citalopram hydrobromide tablets,10 mg, 20 mg and 40 mg. This product is the generic equivalent of Celexa®, a product marketed by Forest Labs, for the treatment of depression with annual brand sales of approximately $1.4 billion. Alpharma will commence an immediate launch of this product.
This is the fourth FDA product approval that the company has received for products manufactured at the company's Elizabeth site since the FDA concluded an inspection at this site.
Alpharma press releases are also available at our website: http://www.alpharma.com/.